Correspondence 0001104659-23-067552 from APPLIED DNA SCIENCES INC (APDN) (CIK 0000744452) (BNBX)
APPLIED DNA SCIENCES INC (APDN) (CIK 0000744452)
Date: June 2, 2023 · CIK: 0000744452 · Accession: 0001104659-23-067552
AI Filing Summary & Sentiment
File numbers found in text: 333-272267
Letter
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, New York 11790
June 2, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Trade & Services
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Jennie Beysolow
Re: Applied DNA Sciences, Inc.
Registration Statement on Form S-3
Filed May 30, 2023
File No. 333-272267
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Applied DNA Sciences, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-272267) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective on Tuesday, June 6, 2023 at 4:30 p.m. (Eastern Time), or as soon thereafter as practicable.
Please feel free to direct any questions or comments concerning this request to Merrill M. Kraines, Esq. of McDermott Will & Emery LLP at (212) 547-5616.
The Company understands that the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
APPLIED DNA SCIENCES, INC.
By: /s/ James Hayward
Name: James Hayward
Title: Chief Executive Officer
cc: Merrill M. Kraines, McDermott Will & Emery LLP
Show Raw Text
CORRESP
1
filename1.htm
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, New York 11790
June 2, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Trade & Services
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Jennie Beysolow
Re:
Applied DNA Sciences, Inc.
Registration Statement on Form S-3
Filed May 30, 2023
File No. 333-272267
Ladies and Gentlemen:
Pursuant to Rule 461 under the
Securities Act of 1933, as amended, Applied DNA Sciences, Inc. (the “Company”) hereby requests that the effective date
of the Company’s Registration Statement on Form S-3 (File No. 333-272267) (the “Registration Statement”) be accelerated
so that the Company’s Registration Statement will become effective on Tuesday, June 6, 2023 at 4:30 p.m. (Eastern
Time), or as soon thereafter as practicable.
Please feel free to direct any
questions or comments concerning this request to Merrill M. Kraines, Esq. of McDermott Will & Emery LLP at (212) 547-5616.
The Company understands that
the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Company that it is
aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration
Statement.
APPLIED DNA SCIENCES, INC.
By:
/s/ James Hayward
Name:
James Hayward
Title:
Chief Executive Officer
cc: Merrill M. Kraines, McDermott Will & Emery LLP